Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy

被引：0
|
作者：
Teofila Seremet
Yanina Jansen
Simon Planken
Hassan Njimi
Mélanie Delaunoy
Hakim El Housni
Gil Awada
Julia Katharina Schwarze
Marleen Keyaerts
Hendrik Everaert
Danielle Lienard
Véronique Del Marmol
Pierre Heimann
Bart Neyns
机构：
[1] Universitair Ziekenhuis Brussel,Department of Medical Oncology
[2] Vrije Universiteit Brussel (VUB),Department of Dermatology
[3] Hôpital Erasme,Department of Biomedical Statistics
[4] Université Libre de Bruxelles (ULB),Laboratory of Molecular Biology in Haemato
[5] Université Libre de Bruxelles (ULB),oncology
[6] LHUB-ULB,Department of Nuclear Medicine
[7] Hôpital Erasme,undefined
[8] Université Libre de Bruxelles (ULB),undefined
[9] Universitair Ziekenhuis Brussel,undefined
[10] Vrije Universiteit Brussel (VUB),undefined
来源：
Journal of Translational Medicine | / 17卷
关键词：
Translational research; Liquid biopsy; Circulating tumor DNA; Monitoring; Immunotherapy; Metastatic melanoma; BRAF/NRAS mutations monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
    Amato, Carol M.
    Hintzsche, Jennifer D.
    Wells, Keith
    Applegate, Allison
    Gorden, Nicholas T.
    Vorwald, Victoria M.
    Tobin, Richard P.
    Nassar, Kelsey
    Shellman, Yiqun G.
    Kim, Jihye
    Medina, Theresa M.
    Rioth, Matthew
    Lewis, Karl D.
    McCarter, Martin D.
    Gonzalez, Rene
    Tan, Aik-Choon
    Robinson, William A.
    CANCERS, 2020, 12 (07) : 1 - 15
  • [22] HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report
    Cabel, Luc
    Bidard, Francois-Clement
    Servois, Vincent
    Cacheux, Wulfran
    Mariani, Pascale
    Romano, Emanuela
    Minsat, Mathieu
    Bieche, Ivan
    Farkhondeh, Fereshteh
    Jeannot, Emmanuelle
    Buecher, Bruno
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (08) : 1667 - 1670
  • [23] Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1
    Lu, Yue
    Ng, Alphonsus H. C.
    Chow, Frances E.
    Everson, Richard G.
    Helmink, Beth A.
    Tetzlaff, Michael T.
    Thakur, Rohit
    Wargo, Jennifer A.
    Cloughesy, Timothy F.
    Prins, Robert M.
    Heath, James R.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [24] FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma
    Tan, A. C.
    Emmett, L.
    Lo, S.
    Liu, V.
    Kapoor, R.
    Carlino, M. S.
    Guminski, A. D.
    Long, G. V.
    Menzies, A. M.
    ANNALS OF ONCOLOGY, 2018, 29 (10) : 2115 - 2120
  • [25] Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy
    Ying Zhou
    Jinmei Zhou
    Xiaopeng Hao
    Haoyuan Shi
    Xuejie Li
    Anqi Wang
    Zhiyuan Hu
    Yanlian Yang
    Zefei Jiang
    Tao Wang
    Breast Cancer Research and Treatment, 2023, 200 : 281 - 291
  • [26] Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy
    Zhou, Ying
    Zhou, Jinmei
    Hao, Xiaopeng
    Shi, Haoyuan
    Li, Xuejie
    Wang, Anqi
    Hu, Zhiyuan
    Yang, Yanlian
    Jiang, Zefei
    Wang, Tao
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 200 (02) : 281 - 291
  • [27] Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders
    Brown, Lauren J.
    Weppler, Alison
    Bhave, Prachi
    Allayous, Clara
    Patrinely, J. Randall, Jr.
    Ott, Patrick
    Sandhu, Shahneen
    Haydon, Andrew
    Lebbe, Celeste
    Johnson, Douglas B.
    Long, Georgina V.
    Menzies, Alexander A.
    Carlino, Matteo S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)
  • [28] Sorting Transcriptomics Immune Information from Tumor Molecular Features Allows Prediction of Response to Anti-PD1 Therapy in Patients with Advanced Melanoma
    Trilla-Fuertes, Lucia
    Gamez-Pozo, Angelo
    Prado-Vazquez, Guillermo
    Lopez-Vacas, Rocio
    Zapater-Moros, Andrea
    Lopez-Camacho, Elena
    Lumbreras-Herrera, Maria, I
    Soriano, Virtudes
    Garicano, Fernando
    Jose Lecumberri, Ma
    Rodriguez de la Borbolla, Maria
    Majem, Margarita
    Perez-Ruiz, Elisabeth
    Gonzalez-Cao, Maria
    Oramas, Juana
    Magdaleno, Alejandra
    Fra, Joaquin
    Martin-Carnicero, Alfonso
    Corral, Monica
    Puertolas, Teresa
    Ramos, Ricardo
    Fresno Vara, Juan Angel
    Espinosa, Enrique
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [29] Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics
    Romain-David Seban
    John S. Nemer
    Aurélien Marabelle
    Randy Yeh
    Eric Deutsch
    Samy Ammari
    Antoine Moya-Plana
    Fatima-Zohra Mokrane
    Robyn D. Gartrell
    Grace Finkel
    Luke Barker
    Amélie E. Bigorgne
    Lawrence H. Schwartz
    Yvonne Saenger
    Caroline Robert
    Laurent Dercle
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 2298 - 2310
  • [30] Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics
    Seban, Romain-David
    Nemer, John S.
    Marabelle, Aurelien
    Yeh, Randy
    Deutsch, Eric
    Ammari, Samy
    Moya-Plana, Antoine
    Mokrane, Fatima-Zohra
    Gartrell, Robyn D.
    Finkel, Grace
    Barker, Luke
    Bigorgne, Amelie E.
    Schwartz, Lawrence H.
    Saenger, Yvonne
    Robert, Caroline
    Dercle, Laurent
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (11) : 2298 - 2310
12345